Mostrando 5 resultados de: 5
Subtipo de publicación
Article(5)
Publisher
Biotecnologia Aplicada(2)
Clinical Nuclear Medicine(1)
Electronic Journal of Biotechnology(1)
Nuclear Medicine Communications(1)
Área temáticas
Enfermedades(5)
Farmacología y terapéutica(4)
Fisiología humana(2)
Medicina y salud(2)
Ginecología, obstetricia, pediatría, geriatría(1)
Área de conocimiento
Enfermedad cardiovascular(3)
Medicina interna(2)
Biología molecular(1)
Ensayo clínico(1)
Inmunología(1)
Origen
scopus(5)
Gene therapy using a plasmid that expresses the VEGF<inf>121</inf> for the treatment of the critical ischemic cardiophaty
ArticleAbstract: Here we report, for the first time in Cuba, the use of gene therapy to evaluate the positive therapePalabras claves:Clinical study, Gene therapy, Vascular endothelial growth factorAutores:Batista J.F., Betancourt B.Y., Chaos N., Chil R., Coca M., Fleites G., García A., García E., Garzón E., González M.J., González N., González R., Guevara L., Guillén-Nieto G.E., Méndez T., Milán R., Naffe M., Quián Y.P., Reina C., Santiago Nelson Vispo, Senra G., Seralena A., Suárez L.R., Vazquez R., Villar A.Fuentes:scopusGene therapy with a plasmid expressing the VEGF<inf>121</inf> for the treatment of critical ischemic cardiopathy
ArticleAbstract: Here we report, for the first time in Cuba, the evaluation of the positive therapeutic action and saPalabras claves:Autores:Batista J.F., Betancourt B.Y., Chaos N., Chil R., Coca M., Fleites G., García A., García E., Garzón E., González M.J., González N., González R., Guevara L., Guillén-Nieto G.E., Méndez T., Milán R., Naffe M., Quián Y.P., Reina C., Santiago Nelson Vispo, Senra G., Seralena A., Suárez L.R., Vazquez R., Villar A.Fuentes:scopusIntramyocardial gene transfer of vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart
ArticleAbstract: Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen that is angiogenicPalabras claves:Collateral development, Coronary artery disease, Gene therapy, Naked plasmid DNA, revascularization, Therapeutic angiogenesisAutores:Alí A., Batista J.F., Chaos N., Coca M., Dominguez H., Garcia-Osuna T., González N., González R., Guevara L., Herrera L., Montequín J.F., Ojalvo A.G., Perera A., Puchades Y., Quián Y.P., Reima C., Reyes J.L., Santiago Nelson Vispo, Seralena A., Silva R., Vazquez R.Fuentes:scopusImmunoscintigraphy with <sup>99m</sup>Tc-nimotuzumab for planning immunotherapy in patients with bone metastases due to prostate cancer
ArticleAbstract: Detection of bone metastases indicates poor prognosis for patients with prostate cancer. The immunotPalabras claves:Bone metastases, Immunoscintigraphy, Monoclonal antibody, nimotuzumab, Prostate cancerAutores:Batista J.F., Perera A., Prats A., Quián Y.P., Tania CrombetFuentes:scopusPhase i/ii clinical trial of the humanized anti-egf-r monoclonal antibody h-r3 labelled with <sup>99m</sup>tc in patients with tumour of epithelial origin
ArticleAbstract: To evaluate the biodistribution, internal radiation dosimetry and toxicity of the humanized MAb h-R3Palabras claves:biodistribution, Dosimetry, Humanized MAb, RadioimmunodiagnosisAutores:Aguilar V., Batista J.F., Coca M.A., Hernández A., Iznaga-Escobar N., Neninger Vinageras E., Perera A., Pérez M., Ramos M., Romero S., Sánchez E., Tania Crombet, Torres L.Fuentes:scopus